Cardiovascular Medicine: An Overview

Course Description

Participants will have the opportunity to learn how cardiovascular clinical trial results influence prescribing. Our experienced speakers will discuss the strengths, limitations, and the actual and/or potential impact, of key clinical trials on prescribing practice. Patient presentations and treatment algorithms will provide worked examples to reinforce the lecture content.

Detailed consideration will be given to a number of disease areas, including dyslipidaemias, myocardial infarction (MI), heart failure and vascular disease. Clinical trials investigating current treatments for these diseases, including statins, ACE inhibitors, beta-blockers and anti-platelet therapy, will be analysed and examples will be drawn from primary and secondary care. The implications of coronary artery disease in diabetes will also be discussed.

The programme will conclude with an overview of the challenge of using the evidence base in developing future strategies for the treatment of cardiovascular disease.

CPD accreditation:
Healthcare's programmes are approved by the Faculty of Pharmaceutical Medicine for CPD accreditation.

Topics to be covered include:

• Overview and clarification of terminology and recent changes in management and treatment goals in:

MI
Acute left ventricular dysfunction and chronic heart failure
Peripheral vascular disease and stroke
Diabetes
Coronary artery disease and diabetes

• Patient presentations and algorithms

• Evidence base – 'Trials to Practice'